Home/SEC 13D/G/ZBIOSEC 13D/GZBIO - Zenas BioPharma, Inc. - SEC Filing Update (19-AUG-2026) | ThinkSabio - Stocks Simplified$ZBIO$31.04βΌ -9.98% YTDOthersAug 19, 2026 Β· ThinkSabio BlogSEC Filing Update: #ZBIO Zenas BioPharma, Inc. : $31.04 Sector: Others | YTD: π½ -9.98% The SEC disclosed Today (19-AUG-2026) that Enavate Sciences GP, LLC has DECREASED #ZBIO Shares by -17.19% π΄ * Previous Holdings: 3.92M Shares * Current Holdings: 3.25M Shares * Decrease -673.75K * Decreased (%)-17.19% * Ownership: 4.9% https://www.thinksabio.com/reports/isr/ZBIO Institutional ownership in #ZBIO has been steadily rising over the past 9 quarters in Shares: Q2 2024: 0.00 Q3 2024: 24.70M Q4 2024: 31.70M Q1 2025: 32.49M Q2 2025: 34.06M Q3 2025: 34.83M Q4 2025: 41.56M Q1 2026: 55.40M Q2 2026: 56.47M Enavate Sciences GP, LLC reduced its shareholding in ZBIO from 3,919,159 shares to 3,245,404 shares, a decrease of 673,755 shares, while maintaining a 4.9% ownership stake. Share this postπCopy Linkπ¬ Comments Loading commentsβ¦Leave a commentPost Commentβ All PostsMore SEC 13D/G